Treatment Access News
Patient Group Input Webinar Consultation: Egrifta
february 12, 2016
Egrifta is a new treatment for excess abdominal fat in people living with HIV with lipodystrophy.
This National Webinar includes information on:
- How patients can influence the drug approval process
- Clinical trial data findings on Egrifta
- Evaluation of whether Egrifta meets the needs of people with lived experience
We want to hear from you!
After viewing the webinar, please take a few moments to answer our online survey. The feedback received will be included in our report to the Common Drug Review.
Deadline for the survey is Mach 24th, 2016.